多発性骨髄腫治療薬の世界市場...市場調査レポートについてご紹介

【英文タイトル】Global Multiple Myeloma Drugs Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Product Profiles
04.1.1 Pomalyst/ Imnovid
04.1.2 Revlimid
04.1.3 Zometa
04.1.4 Doxil/Caelyx
04.1.5 Thalomid/ Thalidomide Celgene
04.1.6 Kyprolis
04.1.7 Mozobil
04.1.8 Velcade

05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology

06.Introduction

07.Disease Overview
07.1 Understanding Multiple Myeloma
07.2 Pathophysiology
07.3 Epidemiology
07.4 Diagnosis
07.5 Staging
07.6 Management
07.7 Economic Burden

08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis

09.Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral

10.Market Segmentation by Dosage Form
10.1 Solid
10.2 Liquid

11.Geographical Segmentation

12.Buying Criteria

13.Market Growth Drivers

14.Drivers and their Impact

15.Market Challenges

16.Impact of Drivers and Challenges

17.Market Trends

18.Trends and their Impact

19.Pipeline Portfolio

20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Celgene
20.2.2 Johnson & Johnson
20.2.3 Novartis
20.2.4 Onyx
20.2.5 Sanofi
20.2.6 Takeda Pharmaceutical
20.3 Other and Future Prominent Vendors

21.Key Vendor Analysis
21.1 Celgene
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Strategy
21.1.4 Business Segmentation by Revenue
21.1.5 Sales by Geography
21.1.6 Key Information
21.1.7 SWOT Analysis
21.2 Johnson & Johnson
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Novartis
21.3.1 Key Facts
21.3.2 Business Description
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison 2012 and 2013
21.3.6 Sales by Geography
21.3.7 Business Strategy
21.3.8 Key Developments
21.3.9 SWOT Analysis
21.4 Onyx Pharmaceuticals
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Marketed Products
21.4.4 Geographical Segmentation
21.4.5 Business Strategy
21.4.6 Recent Developments
21.4.7 SWOT Analysis
21.5 Sanofi
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2013
21.5.4 Business Segmentation by Revenue 2012 and 2013
21.5.5 Geographical Segmentation by Revenue 2013
21.5.6 Business Strategy
21.5.7 Key Developments
21.5.8 SWOT Analysis
21.6 Takeda Pharmaceutical
21.6.1 Key Facts
21.6.2 Business Overview
21.6.3 Business Segmentation by Revenue 2013
21.6.4 Business Segmentation by Revenue 2013
21.6.5 Geographical Segmentation by Revenue 2013
21.6.6 Business Strategy
21.6.7 Recent Developments
21.6.8 SWOT Analysis

22.Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Pathophysiology of Multiple Myeloma
Exhibit 3: Indicators of Multiple Myeloma
Exhibit 4: Laboratory Tests to Identify Multiple Myeloma
Exhibit 5: Diagnosis of Multiple Myeloma
Exhibit 6: Staging of Multiple Myeloma
Exhibit 7: Management of Multiple Myeloma
Exhibit 8: Induction Therapy Recommendations for the Transplant Eligible Candidates
Exhibit 9: Maintenance Therapy for the Candidates with Multiple Myeloma
Exhibit 10: Supportive Therapy for the Candidates with Multiple Myeloma
Exhibit 11: Estimated Expenditure for the Four Type of Treatment Regimens for Multiple Myeloma in the US
Exhibit 12: Snapshot of the Economic Burden of Multiple Myeloma
Exhibit 13: Snapshot of Global Multiple Myeloma Drugs Market 2014
Exhibit 14: Global Multiple Myeloma Drugs Market 2014-2019 (US$ million)
Exhibit 15: Global Multiple Myeloma Drugs Market Segmentation By Route Of Administration
Exhibit 16: Global Multiple Myeloma Drugs Market Segmentation by Route of Administration 2014
Exhibit 17: Global Multiple Myeloma Drugs Market Segmentation by Dosage Form
Exhibit 18: Global Multiple Myeloma Drugs Market Segmentation by Dosage Form 2014
Exhibit 19: Global Multiple Myeloma Drugs Market by Geographical Segmentation 2014
Exhibit 20: Buying Criteria of Global Multiple Myeloma Drugs Market 2014
Exhibit 21: Growth Drivers of the Global Multiple Myeloma Drugs Market
Exhibit 22: Drivers and their Impact on the Key Customer Category of Global Multiple Myeloma Drugs Market 2014
Exhibit 23: Drivers and their Impact on the Geographies of Global Multiple Myeloma Drugs Market 2014
Exhibit 24: Challenges of the Global Multiple Myeloma Drugs Market
Exhibit 25: Trends of the Global Multiple Myeloma Drugs Market
Exhibit 26: Phase III Pipeline Molecules for Multiple Myeloma
Exhibit 27: Global Multiple Myeloma Drugs Market Share Analysis 2014
Exhibit 28: Sales Forecast of Pomalyst 2014-2018 (US$ million)
Exhibit 29: YoY Sales Comparison of Revlimid 2007-2013 (US$ million)
Exhibit 30: Sales Forecast of Revlimid 2014-2018 (US$ million)
Exhibit 31: YoY Sales Comparison of Thalomid 2007-2013 (US$ million)
Exhibit 32: Sales Forecast of Thalomid 2014-2018 (US$ million)
Exhibit 33: YoY Sales Comparison of Velcade outside the US 2008-2013 (US$ million)
Exhibit 34: Sales Comparison of Zometa in the US and ROW 2007-2013 (US$ million)
Exhibit 35: Global YoY Sales Comparison of Zometa 2007-2013 (US$ million)
Exhibit 36: YoY Sales Comparison of Zometa in the US 2007-2013 (US$ million)
Exhibit 37: YoY Sales Comparison of Zometa in ROW 2007-2013 (US$ million)
Exhibit 38: Sales Forecast of Kyprolis 2014-2018 (US$ million)
Exhibit 39: Global YoY Sales Comparison of Mozobil 2007-2013 (US$ million)
Exhibit 40: Global YoY Sales Comparison of Velcade in Japan 2009-2013 (US$ million)
Exhibit 41: Sales Forecast of Velcade 2014-2018 (US$ million)
Exhibit 42: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 43: Celgene: Sales by Geography 2013
Exhibit 44: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 45: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 46: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Exhibit 47: Novartis AG: Business Segmentation
Exhibit 48: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 49: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 50: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 51: Onyx Pharmaceuticals: Marketed Products
Exhibit 52: Onyx Pharmaceuticals: Geographical Segmentation
Exhibit 53: Sanofi: Business Segmentation by Revenue 2013
Exhibit 54: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 55: Sanofi: Geographical Segmentation by Revenue 2013
Exhibit 56: Takeda Pharmaceuticals: Business Segmentation by Revenue 2013
Exhibit 57: Takeda Pharmaceuticals: Business Segmentation by Revenue 2013 (US$ million)
Exhibit 58: Takeda Pharmaceuticals: Geographical Segmentation by Revenue 2013


【レポート販売概要】

■ タイトル:多発性骨髄腫治療薬の世界市場
■ 英文:Global Multiple Myeloma Drugs Market 2015-2019
■ 発行日:2014年12月3日
■ 調査会社:Technavio
■ 商品コード:IRTNTR4753
■ 調査対象地域:グローバル
  • 農業用酵素の世界市場:カルボヒドラーゼ、プロテアーゼ、リパーゼ
    About Agricultural Enzymes Agricultural enzymes are complex protein molecules derived from sources such as plant tissue, animal tissue, and microbes. They accelerate chemical reactions and catalyze biochemical reactions that do not occur naturally. Based on type, agricultural enzymes are segmented into carbohydrases, proteases, lipases, and others. They are used in fertility, and growth-enhancing …
  • Pioneer Surgical Technology, Inc.:市場シェア分析
    Pioneer Surgical Technology, Inc. Market Share Analysis Summary GlobalData’s new report, “Pioneer Surgical Technology, Inc. Market Share Analysis” provides in-depth information on Pioneer Surgical Technology, Inc.’s market position in the different medical equipment markets it operates in. The report provides Pioneer Surgical Technology, Inc. market share information in one key market category – S …
  • 世界のデジタルカメラ市場動向
    To maximize product differentiation, smartphone brands have been upgrading their camera modules for improved photo quality. Their efforts in advancing smartphone photography, however, have jeopardized the global digital camera market. This is especially detrimental to the survival of entry-level and mid-range digital cameras. For this reason, digital camera brands have been repositioning their pro …
  • オキシ塩化チタンの世界市場
    Titanium Oxychloride (CAS 92344-13-3) Market Research Report 2014 presents comprehensive data on titanium oxychloride markets globally and regionally (Europe, Asia, North America etc.) The report includes titanium oxychloride description, covers its application areas and related patterns. It overviews titanium oxychloride market, names titanium oxychloride producers and indicates its suppliers. Be …
  • 世界の鎮痛剤注入ポンプ市場2015
    The Global Analgesic Infusion Pumps Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Analgesic Infusion Pumps industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Analgesic Infusion Pumps market analysis is provided for the international markets inclu …
  • 航空・防衛用遠隔測定システムの世界市場
    About Aerospace and Defense Telemetry Telemetry is an automated mode of communication that is used for the measurement of data received from remote and inaccessible points. It can be through wired mode (telephone networks and optical links) or wireless mechanisms (radio, infrared, and ultrasonic waves). Aerospace and defense telemetry transmit information from satellites, spacecraft, or defense sy …
  • 医療用接着剤の世界市場:コラーゲン接着剤、フィブリン接着剤、合成樹脂接着剤
    The report covers the global medical adhesives market and further segments the market on the basis of resin type, formulating technology, application, and region. The market data for these types is given with respect to volume (kilotons) and value ($million). The global market value of medical adhesives is estimated to be $6,318.92 million in 2014 and is projected to grow at a CAGR of about 9.43% …
  • 慢性安定狭心症:世界の治験レビュー(2015年上半期版)
    Chronic Stable Angina Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Chronic Stable Angina Global Clinical Trials Review, H1, 2015" provides an overview of Chronic Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Stable Angina. Report includes an overview of trial numbers and their average en …
  • o-キシレンの世界市場動向及び予測2015
    The present report is an essential resource for a one looking for detailed information on the world orthoxylene market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insig …
  • ソフトドリンク及びホットドリンク市場の新規事業機会
    Summary “Identifying new opportunities in the Soft and Hot Drink markets and responding to evolving consumer need states” provides detailed insight into new opportunities in Soft Drinks and Hot Drinks in both developing and developed countries. The evolution of consumption habits across the world means both retailers and manufacturers need a renewed understanding of consumer’s changing lifestyles, …
  • OMV Aktiengesellschaft:石油・ガスバリューチェーン分析レポート2013
    OMV Aktiengesellschaft Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "OMV Aktiengesellschaft" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “OMV Aktiengesellschaft”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
  • sfRowasa(潰瘍性大腸炎):市場分析と予測(~2022)
    sfRowasa (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affectin …
  • 民間航空機用バッテリーの世界市場:ニッケルカドミウムバッテリー、リチウムバッテリー
    The global commercial aircraft batteries and accessories market is estimated to grow at a CAGR of 7.3% from 2014 to 2019. Although the developing markets (such as the China, India, and Japan) hold larger shares in the global commercial aircraft batteries and accessories market, the Middle East region is expected to grow at the fastest CAGR of 8.4% during the forecast period, 2014 to 2019. The grow …
  • 安息香酸ナトリウムの世界市場2017-2021
    ABSTRACTAbout Sodium Benzoate Sodium benzoate is the sodium salt of benzoic acid. Naturally, sodium benzoate is found in several fruits such as apples, berries, plums, clove, and cinnamons. It is a water-soluble compound and mainly used as a preservative in various applications such as food, beverage, pharmaceuticals, and personal care. Sodium benzoate is predominantly used in food and beverage ap …
  • リチウムイオン電池の世界市場2016-2020
    About Li-ion Batteries Li-ion batteries are rechargeable batteries in which the Li-ion acts as the cathode and the carbon acts as the anode. Li-ion batteries have a good electrochemical performance with low resistance. The advantage of using Li-ion batteries is that they increase the thermal stability, have higher current density, and a longer shelf life as compared with other batteries available …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。